Camille Nelson Kotton MD, FIDSA, FAST is the clinical director of the Transplant Infectious Disease and Immunocompromised Host Program at the Massachusetts General Hospital, and Associate Professor of Medicine, Harvard Medical School, Boston, Massachusetts. She is the past chair of The Infectious Disease Community of Practice of The American Society of Transplantation. From 2007-2013, she was the president of The Transplant Infectious Disease Section of The Transplantation Society. Highlights of her time as president include the development of international guidelines on CMV management after solid organ transplant, followed by an updated version, published in Transplantation (2010 and 2013). Her clinical interests include cytomegalovirus, donor-derived infections, zoonoses, and travel and tropical medicine in the transplant setting.
Laura M. Dember, M.D. is a Professor of Medicine and Epidemiology at the University of Pennsylvania Perelman School of Medicine where she is a faculty member in the Renal-Electrolyte and Hypertension Division and a Senior Scholar in the Center for Clinical Epidemiology and Biostatistics. Dr. Dember conducts patient-oriented research in chronic kidney disease and end-stage renal disease and has particular interests in hemodialysis vascular access and interventions to improve clinical outcomes for patients treated with maintenance hemodialysis. She has leadership roles in several multicenter observational studies and clinical trials including the Dialysis Access Consortium, the Hemodialysis Fistula Maturation Study, the Hemodialysis Novel Therapies Consortium, and the TiME Trial, all funded by the US National Institutes of Health. She has clinical expertise in the systemic amyloidoses and has been involved in the development of new treatment approaches for this group of disorders. Dr. Dember has been a member of several committees of the American Society of Nephrology and is a Deputy Editor for the American Journal of Kidney Diseases.
Charmaine E. Lok, BSc(PT), MD, MSC, FRCP(C) is a Professor of Medicine at the University of Toronto (U of T). She is graduate faculty in the Clinical Epidemiology & Health Care Research Program, Department of Health Policy, Management and Evaluation (U of T) and the Department of Clinical Epidemiology and Biostatistics, Faculty of Health Sciences, McMaster University. Dr. Lok is the Medical Director of both the multidisciplinary chronic kidney disease (CKD) and hemodialysis programs at the University Health Network-Toronto General Hospital, Toronto, Canada. She is a Senior Scientist at the Toronto General Research Institute with research interests in patient health outcomes and functional ability in CKD, hemodialysis vascular access and cardiovascular disease in endstage renal disease (ESRD). Dr. Lok is also active in raising awareness of CKD and ESKD and its importance in public health. She is involved in a variety of local and international scientific and educational programs, including ASN, CIHR, DOPPS, KFOC, NKF, and Kidney CARE Network International.
Jacquot Award Past Recipients
Katherine Barraclough is a Consultant Nephrologist at the Royal Melbourne Hospital. She completed her basic medical training in Melbourne then undertook advanced training in Nephrology in Vancouver, Canada, New Delhi India and Brisbane, Australia. She subsequently completed a PhD through the University of Queensland (2012) undertaking clinical research examining pharmacogenetic, pharmaocokinetic and pharmaocdynamic monitoring of immunosuppressive therapy in adult kidney transplant recipients.
Over the years her primary research interests have included individualization of immunosuppression in kidney transplantation and Indigenous Australian renal health and disease. More recently, she has focused her attention on the issue of environmental sustainability within the health care system and the intersection between planetary and human health. She is current Chair of the Victorian Nephrology Environmental Sustainability Special Interest Group and the ANZSN Green Nephrology Working Group. She is also a committee member of the Victorian branch for Doctors for the Environment.
Natasha Rogers is a Consultant Nephrologist and Transplant physician at Westmead Hospital. She completed her basic medical training in Adelaide and her advanced training in Nephrology at the Royal Darwin and Queen Elizabeth Hospitals. She undertook a PhD in the Transplant Immunology Laboratory through the University of Adelaide focusing on dendritic cell immunobiology. In 2011 she moved to the University of Pittsburgh as a postdoctoral fellow supported by the NHMRC, American Heart Association and American Society of Transplantation. Her research centred on the thrombospondin-1-CD47 pathway in acute kidney injury and repair.
Natasha returned to Australia in 2016 to establish a basic science research laboratory at the Westmead Institute for Medical Research, where she is a Senior Research Fellow. She maintains close collaborative links with colleagues in the Starzl Transplant Institute in Pittsburgh, and is appointed as an Adjunct Assistant Professor. Her current research interests are in kidney injury and repair and vascular biology.